Uncertainty over the future of AstraZeneca Chief Executive Pascal Soriot drove the Anglo-Swedish drugmaker's shares lower again on Friday, taking the cost of two days of silence to more than 3 billion pounds ($3.9 billion). Ciara Lee reports.
Peoples are using these keywords: Pascal soriot, Pascal soriotshare price, ceo, Astra zeneca, Share price

You might also like this

Speak Your Mind